Purdue Pharma and Sackler Family Reach $7.4 Billion Settlement Over Opioid Crisis

Purdue Pharma and Sackler family agree to a $7.4 billion settlement to address opioid crisis lawsuits, subject to court approval.

Overview

A summary of the key points of this story verified across multiple sources.

Purdue Pharma and the Sackler family have agreed to pay up to $7.4 billion to settle lawsuits related to the opioid crisis, significantly increasing their previous settlement by over $1 billion. The Sacklers will contribute $6.5 billion and Purdue $900 million. This deal aims to compensate victims and fund opioid addiction treatment, but requires court approval. The arrangement ends Sackler control over Purdue and restricts them from selling opioids in the U.S. Several state attorney generals participated in this negotiation, seeing it as a means to provide some closure to opioid crisis victims.

Written using shared reports from
10 sources
.
Report issue

Analysis

Compare how each side frames the story — including which facts they emphasize or leave out.

Analysis unavailable for this viewpoint.